Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms.

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from those breakthroughs to make new progress.

Long COVID shows varied recovery trajectories, with distinct symptom patterns identified in the RECOVER cohort, emphasizing the need for personalized care.

In the midst of the backlash against the CDC’s guidance, a recent Harvard University study highlights a new risk of COVID-19 during pregnancy. In a rare look at the children of women who contracted COVID-19 while pregnant, the study found that they may be at increased risk for autism and other neurodevelopmental diagnoses by age 3.

About 5% of U.S. adults are estimated to be living with long COVID-19, and one of them is UC San Francisco epidemiologist and long COVID researcher Alison Cohen, PhD, MPH. Cohen, who was involved in COVID-19 research since the beginning of the pandemic ...

New research reveals a drug that might actually help save severely ill patients, and data suggests that distancing policies may have saved millions of lives over the last few months. Hosted by: Hank Green SciShow has a spinoff podcast!

Introduction The COVID-19 pandemic is expected to have impacted many drivers of antimicrobial resistance (AMR) and compounded existing societal and health inequities. This rapid scoping review examined how three selected healthcare system factors,

Langone researchers found that people may unknowingly retain a reduced sense of smell years after having COVID-19, according to a report that measured perception of odors, or olfactory functions. Researchers surveyed over 3,

The 40 million euros fund for long COVID research is nearly depleted, according to a NOS survey of doctors, researchers, patient organizations, and funding institutions. Scientists can submit proposals for the final grants until the end of the year,

Makary, a former professor at the Johns Hopkins School of Medicine, explained to “Pod Force One” host Miranda Devine that as director of the National Institute of Allergy and Infectious Disease